ARTICLE | Distillery Therapeutics
Cancer
June 13, 2017 8:23 PM UTC
Cell culture and mouse studies identified a piperazine-azaindoline-based dual BIRC2/XIAP antagonist that could help treat breast cancer and melanoma. Chemical synthesis and testing of piperazine-azain...